Abstract
Leydig cell tumors are the most common type of testicular sex cord stromal tumors. The presence of the Y chromosome is associated with tumor risk in sex development disorders (DSD), however tumor development without Y chromosome is extremely rare. A 16-year-old boy diagnosed with Leydig cell tumor due to a mass in the right testis was referred after the right orchiectomy. On physical examination, the left testis was 10 mL, and there was a labial residue in penoscrotal region. Bilateral gynecomastia was present. The karyotype was 46,XX and SRY was double-positive on fluorescent in situ hybridization analysis. Ifosfamide, carboplatin and etoposide chemotherapy was initiated due to the Leydig cell tumor. Here, we report the first pediatric case having 46,XX testicular DSD with double-positive SRY and a Leydig cell tumor.
Keywords: Leydig cell tumor, sex determining region of Y-chromosome, testicular DSD
Read the full text
4 sections · 3 figures · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Ashfaq S, Siddiqui A, Shafiq W, Azmat U. A rare presentation of disorder of sex development. Cureus. 2021;13:e12782.
Osaka A, Ide H, Matsuoka K, Iwahata T, Kobori Y, Ban S, Okada H, Saito K. SRY-positive 46, XX testicular disorder of sexual development with Leydig cell tumor. Am J Mens Health. 2020;14:1557988320970071.
Delachapelle A, Hortling H, Niemi M, Wennstroem J. XX sex chromosomes in a human male. First case. Acta Med Scand. 1964;175:Suppl 412:25-28.
Pleskacova J, Hersmus R, Oosterhuis JW, Setyawati BA, Faradz SM, Cools M, Wolffenbuttel KP, Lebl J, Drop SL, Looijenga LH. Tumor risk in disorders of sex development. Sex Dev. 2010;4:259-269. Epub 2010 Jun 17.
Dilworth JP, Farrow GM, Oesterling JE. Non-germ cell tumors of testis. Urology. 1991;37:399-417.
Conkey DS, Howard GC, Grigor KM, McLaren DB, Kerr GR. Testicular sex cord-stromal tumours: the Edinburgh experience 1988-2002, and a review of the literature. Clin Oncol (R Coll Radiol). 2005;17:322-327.
Wachtel SS. XX sex reversal in the human. In: Wachtel SS, editor. Molecular genetics of sex determination. San Diego, CA, USA: Academic Press;1994:267.
Zenteno-Ruiz JC, Kofman-Alfaro S, Méndez JP. 46,XX sex reversal. Arch Med Res. 2001;32:559-566.
Délot EC, Vilain EJ. Nonsyndromic 46,XX Testicular Disorders/Differences of Sex Development. 2003 Oct 30 [updated 2022 May 26]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. PMID: 20301589.
Nakashima S, Ohishi A, Takada F, Kawamura H, Igarashi M, Fukami M, Ogata T. Clinical and molecular studies in four patients with SRY-positive 46, XX testicular disorders of sex development: implications for variable sex development and genomic rearrangements. J Hum Genet. 2014;59:549-553.
Premi S, Srivastava J, Chandy SP, Ahmad J, Ali S. Tandem duplication and copy number polymorphism of the SRY gene in patients with sex chromosome anomalies and males exposed to natural background radiation. Mol Hum Reprod. 2006;12:113-121. Epub 2006 Mar 1
Mooney KL, Kao CS. A contemporary review of common adult non-germ cell tumors of the testis and paratestis. Surg Pathol Clin. 2018;11:739-758. Epub 2018 Oct 17
Farkas LM, Székely JG, Pusztai C, Baki M. High frequency of metastatic Leydig cell testicular tumours. Oncology. 2000;59:118-121.
Fankhauser CD, Grogg JB, Hayoz S, Wettstein MS, Dieckmann KP, Sulser T, Bode PK, Clarke NW, Beyer J, Hermanns T. Risk factors and treatment outcomes of 1,375 patients with testicular Leydig cell tumors: analysis of published case series data. J Urol. 2020;203:949-956. Epub 2019 Dec 17
